Investment firm Baird has revised its price target for Agilon Health (AGL, Financial), lowering it from $6 to $5, while maintaining a Neutral rating on the stock. This decision reflects a cautious outlook amid ongoing policy uncertainties impacting the managed care and healthcare facilities sector.
Baird expresses concern over the lack of significant new investors in the sector until current policy issues are resolved. Furthermore, the firm anticipates that companies within this group will not be raising their financial guidance for the time being. This conservative approach is in response to potential challenges, such as Part D risks and broader macroeconomic headwinds, which could surface later in the year.
Overall, Baird's adjusted expectations underscore the cautious stance firms are adopting in the face of a complex regulatory environment, impacting stock valuations like Agilon Health (AGL, Financial).
Wall Street Analysts Forecast
Based on the one-year price targets offered by 15 analysts, the average target price for Agilon Health Inc (AGL, Financial) is $4.01 with a high estimate of $8.50 and a low estimate of $2.00. The average target implies an downside of 28.33% from the current price of $5.60. More detailed estimate data can be found on the Agilon Health Inc (AGL) Forecast page.
Based on the consensus recommendation from 22 brokerage firms, Agilon Health Inc's (AGL, Financial) average brokerage recommendation is currently 2.9, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Agilon Health Inc (AGL, Financial) in one year is $36.86, suggesting a upside of 558.21% from the current price of $5.6. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Agilon Health Inc (AGL) Summary page.
